Generated by All in One SEO v4.9.4.1, this is an llms.txt file, used by LLMs to index the site.

# A Better Life Pharma

2nd Generation Psychedelics

## Sitemaps

- [XML Sitemap](https://abetterlifepharma.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [BetterLife Pharma Highlights Advantages of BETR-001  – a Potent Neuroplastogen](https://abetterlifepharma.com/betterlife-pharma-highlights-advantages-of-betr-001-a-potent-neuroplastogen/)
- [BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor](https://abetterlifepharma.com/betterlife-pharma-welcomes-daniel-carcillo-as-corporate-advisor/)
- [BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor](https://abetterlifepharma.com/betterlife-pharma-appoints-doug-drysdale-as-corporate-advisor/)
- [USPTO Files ISSUE NOTIFICATION for BetterLife’s BETR-001 Composition of Matter Patent](https://abetterlifepharma.com/uspto-files-issue-notification-for-betterlifes-betr-001-composition-of-matter-patent/)
- [BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001](https://abetterlifepharma.com/betterlife-pharma-provides-scientific-update-on-neuroplastogenic-activity-of-betr-001/)
- [BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders](https://abetterlifepharma.com/betterlife-pharma-provides-scientific-update-of-mechanism-of-action-of-betr-001-in-treatment-of-psychiatric-disorders/)
- [BetterLife Pharma Appoints Corporate Advisor](https://abetterlifepharma.com/betterlife-pharma-appoints-corporate-advisor/)
- [BetterLife Pharma Appoints New Director](https://abetterlifepharma.com/betterlife-pharma-appoints-new-director/)
- [USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent](https://abetterlifepharma.com/uspto-grants-betterlifes-betr-001-composition-of-matter-patent/)
- [BetterLife Announces Favorable Outcome in New York Legal Claims](https://abetterlifepharma.com/betterlife-announces-favorable-outcome-in-new-york-legal-claims/)
- [BetterLife Obtains Favourable Cardiac Safety  Data for BETR-001](https://abetterlifepharma.com/betterlife-obtains-favourable-cardiac-safety-data-for-betr-001/)
- [BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001](https://abetterlifepharma.com/betterlife-obtains-favourable-genotoxicity-data-for-oral-betr-001/)
- [BetterLife Announces Fully Subscribed Private Placement Financing](https://abetterlifepharma.com/betterlife-announces-fully-subscribed-private-placement-financing/)
- [BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent](https://abetterlifepharma.com/betterlife-highlights-advantages-of-non-hallucinogenic-lsd-derivative-betr-001-and-publication-of-its-methods-to-treat-mood-disorders-patent/)
- [Amendment of Disclosures in Past Management Information Circulars](https://abetterlifepharma.com/amendment-of-disclosures-in-past-management-information-circulars/)
- [BetterLife Announces Closing of a Private Placement](https://abetterlifepharma.com/betterlife-announces-closing-of-a-private-placement-3/)
- [BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria](https://abetterlifepharma.com/betterlife-to-present-betr-001-preclinical-data-at-the-2024-conference-of-the-federation-of-european-neuroscience-societies-fens-in-vienna-austria/)
- [BetterLife Announces Closing of a Private Placement](https://abetterlifepharma.com/betterlife-announces-closing-of-a-private-placement-2/)
- [BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001](https://abetterlifepharma.com/betterlife-obtains-excellent-animal-cardiopulmonary-safety-data-for-oral-betr-001/)
- [BetterLife Announces Intent to Complete Private Placement of Units](https://abetterlifepharma.com/betterlife-announces-intent-to-complete-private-placement-of-units/)
- [BetterLife Advances BETR-001 IND-enabling Studies](https://abetterlifepharma.com/betterlife-advances-betr-001-ind-enabling-studies/)
- [BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference](https://abetterlifepharma.com/betterlife-to-present-at-the-2024-bloom-burton-co-healthcare-investor-conference/)
- [BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non- hallucinogenic LSD-based Drug Candidate BETR-001](https://abetterlifepharma.com/betterlife-announces-closing-of-1-168-million-convertible-debentures-to-further-advance-ind-enabling-studies-of-its-non-hallucinogenic-lsd-based-drug-candidate-betr-001/)
- [BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University](https://abetterlifepharma.com/betterlifes-2-bromo-lsd-for-treatment-of-depression-highlighted-by-carleton-university/)
- [BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001](https://abetterlifepharma.com/betterlife-announces-closing-of-convertible-debentures-for-further-development-of-betr-001/)
- [BetterLife Announces Closing of a Private Placement](https://abetterlifepharma.com/betterlife-announces-closing-of-a-private-placement/)
- [BetterLife Announces Extension of Warrants](https://abetterlifepharma.com/betterlife-announces-extension-of-warrants/)
- [US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives](https://abetterlifepharma.com/us-patent-and-trademark-office-publishes-betterlifes-comprehensive-patent-for-betr-001-and-other-lsd-derivatives/)
- [BetterLife Pharma to Host Investors Update Call on September 18, 2023](https://abetterlifepharma.com/betterlife-pharma-to-host-investors-update-call-on-september-18-2023/)
- [BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001](https://abetterlifepharma.com/betterlife-obtains-favourable-animal-safety-data-for-repeated-oral-dosing-of-betr-001/)
- [BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement](https://abetterlifepharma.com/betterlife-highlights-betr-001-article-in-technology-networks-drug-discovery-and-announces-closing-of-a-private-placement/)
- [BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement](https://abetterlifepharma.com/betterlife-highlights-american-college-of-physicians-updated-guidelines-for-treating-depression-and-announces-closing-of-private-placement/)
- [BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives](https://abetterlifepharma.com/betterlife-fast-tracks-its-us-patent-for-betr-001-and-other-lsd-derivatives/)
- [BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada](https://abetterlifepharma.com/betterlife-to-present-betr-001-preclinical-data-at-the-32nd-annual-meeting-of-the-international-behavioural-neuroscience-society-ibns-in-niagara-falls-ontario-canada/)
- [BetterLife Continues Progress on BETR-001 IND-Enabling Studies](https://abetterlifepharma.com/betterlife-continues-progress-on-betr-001-ind-enabling-studies/)
- [BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California](https://abetterlifepharma.com/betterlife-to-present-betr-001-preclinical-data-at-the-2023-annual-meeting-of-the-society-of-biological-psychiatry-sobp-in-san-diego-california/)
- [BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference](https://abetterlifepharma.com/betterlife-to-present-at-the-2023-bloom-burton-co-healthcare-investor-conference/)
- [BetterLife reicht Patentantrag für sein Psychedelika-Derivat der zweiten Generation für 2-Bromo-LSD zur Behandlung der Major Depression ein](https://abetterlifepharma.com/betterlife-reicht-patentantrag-fur-sein-psychedelika-derivat-der-zweiten-generation-fur-2-bromo-lsd-zur-behandlung-der-major-depression-ein/)
- [BetterLife Files Patent for the Treatment of MDD Utilizing its Second-Generation Psychedelic Derivative for 2-Bromo-LSD](https://abetterlifepharma.com/betterlife-files-patent-for-the-treatment-of-mdd-utilizing-its-second-generation-psychedelic-derivative-for-2-bromo-lsd-2/)
- [BetterLife Provides Shareholder Update and 2021 Product Development Roadmap](https://abetterlifepharma.com/betterlife-provides-shareholder-update-and-2021-product-development-roadmap/)
- [Health Canada bestätigt BetterLife: 2-Bromo-LSD ist kein kontrollierter Stoff](https://abetterlifepharma.com/health-canada-bestatigt-betterlife-2-bromo-lsd-ist-kein-kontrollierter-stoff/)
- [BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada](https://abetterlifepharma.com/betterlife-confirms-non-controlled-status-of-2-bromo-lsd-with-health-canada/)
- [BetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in Indonesia](https://abetterlifepharma.com/betterlife-selects-cro-to-conduct-clinical-trials-for-ap-003-in-covid-19-cases-in-indonesia/)
- [BetterLife Demonstrates 6 months Refrigerated Stability of its Proprietary Interferon Formulation to be Developed to Treat Early Stage Covid-19 Cases](https://abetterlifepharma.com/betterlife-demonstrates-6-months-refrigerated-stability-of-its-proprietary-interferon-formulation-to-be-developed-to-treat-early-stage-covid-19-cases/)
- [BetterLife beauftragt Eurofins Discovery mit der Durchführung pharmakologischer Studien für IND-Genehmigung von 2-Bromo-LSD der zweiten Generation](https://abetterlifepharma.com/betterlife-beauftragt-eurofins-discovery-mit-der-durchfuhrung-pharmakologischer-studien-fur-ind-genehmigung-von-2-bromo-lsd-der-zweiten-generation/)
- [BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies](https://abetterlifepharma.com/betterlife-engages-eurofins-discovery-for-its-next-generation-psychedelics-2-bromo-lsd-fda-ind-enabling-pharmacology-studies/)
- [BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder](https://abetterlifepharma.com/betterlife-files-patent-protection-on-dihydrohonokiol-b-for-treatment-of-anxiolytic-use-disorder/)
- [BetterLife to Present at the Emerging Growth Conference on February 17, 2021](https://abetterlifepharma.com/betterlife-to-present-at-the-emerging-growth-conference-on-february-17-2021/)
- [BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing](https://abetterlifepharma.com/betterlife-engages-eurofins-cdmo-for-next-generation-psychedelic-td-0148a-manufacturing/)
- [BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies](https://abetterlifepharma.com/betterlife-enters-research-agreement-with-carleton-university-for-td-0148a-depression-studies/)
- [BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003](https://abetterlifepharma.com/betterlife-subsidiary-altum-pharmaceuticals-to-conduct-randomized-placebo-controlled-covid-19-trial-using-ap-003/)
- [BetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology Studies](https://abetterlifepharma.com/betterlife-enters-into-research-agreement-with-ucsd-for-td-0148a-behavioural-pharmacology-studies/)
- [BetterLife Added to Horizons Psychedelic Stock Index ETF Announces Closing of Non-Brokered Private Placement](https://abetterlifepharma.com/betterlife-added-to-horizons-psychedelic-stock-index-etf-announces-closing-of-non-brokered-private-placement/)
- [Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor](https://abetterlifepharma.com/former-fda-psychiatry-division-director-dr-thomas-laughren-joins-betterlife-as-regulatory-advisor/)
- [BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs](https://abetterlifepharma.com/betterlife-files-patent-for-invention-of-novel-subcutaneous-implant-to-prevent-drug-diversion-of-lsd-and-other-psychedelic-drugs/)
- [BetterLife Announces Closing of a Non-Brokered Private Placement](https://abetterlifepharma.com/betterlife-announces-closing-of-a-non-brokered-private-placement/)
- [BETTERLIFE ANNOUNCES $5.5 MILLION BOUGHT-DEAL PUBLIC OFFERING OF UNITS](https://abetterlifepharma.com/betterlife-announces-5-5-million-bought-deal-public-offering-of-units/)
- [BetterLife Closes $6.325 Million Bought Deal Public Offering of Units, Including Full Exercise of the Over-Allotment Option](https://abetterlifepharma.com/betterlife-closes-6-325-million-bought-deal-public-offering-of-units-including-full-exercise-of-the-over-allotment-option/)
- [BETTERLIFE ANNOUNCES MARKETED PUBLIC OFFERING OF UNITS FOR UP TO $2.6 MILLION](https://abetterlifepharma.com/betterlife-announces-marketed-public-offering-of-units-for-up-to-2-6-million/)
- [BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors](https://abetterlifepharma.com/betterlife-pharma-appoints-henri-sant-cassia-of-the-conscious-fund-to-its-board-of-directors-2/)
- [BetterLife Closes $2.61 Million Marketed Public Offering](https://abetterlifepharma.com/betterlife-closes-2-61-million-marketed-public-offering/)
- [BetterLife Pharma Retains Proactive Investors and Psychedelic Finance for Market Awareness](https://abetterlifepharma.com/betterlife-pharma-retains-proactive-investors-and-psychedelic-finance-for-market-awareness/)
- [BetterLife Pharma to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th](https://abetterlifepharma.com/betterlife-pharma-to-present-at-the-h-c-wainwright-psychedelics-in-psychiatry-and-beyond-virtual-conference-on-june-17th/)
- [BetterLife Pharma Engages Global Financial and Corporate Communications Agency](https://abetterlifepharma.com/betterlife-pharma-engages-global-financial-and-corporate-communications-agency-2/)
- [BetterLife Pharma Engages Global Financial and Corporate Communications Agency](https://abetterlifepharma.com/betterlife-pharma-engages-global-financial-and-corporate-communications-agency/)
- [BetterLife Secures Mitacs Funding in Collaboration with Carleton University Research Team for TD-0148A Preclinical Depression Studies](https://abetterlifepharma.com/betterlife-secures-mitacs-funding-in-collaboration-with-carleton-university-research-team-for-td-0148a-preclinical-depression-studies/)
- [BetterLife Announces Exercise of Over-Allotment Option in Public Offering](https://abetterlifepharma.com/betterlife-announces-exercise-of-over-allotment-option-in-public-offering/)
- [BetterLife Provides H1 2021 Progress Update](https://abetterlifepharma.com/betterlife-provides-h1-2021-progress-update/)
- [Early Results of BetterLife Preclinical Study Showing AP-003 (rhIFNa2b) has Similar Potent Efficacy Against Different Variants of COVID-19](https://abetterlifepharma.com/early-results-of-betterlife-preclinical-study-showing-ap-003-rhifna2b-has-similar-potent-efficacy-against-different-variants-of-covid-19/)
- [BetterLife to Present at the Emerging Growth Conference](https://abetterlifepharma.com/betterlife-to-present-at-the-emerging-growth-conference/)
- [BetterLife-Carleton University Research Team Secure Mitacs Accelerate Funding to Study the Therapeutic Effect of TD-010 in Chronic Anxiety](https://abetterlifepharma.com/betterlife-carleton-university-research-team-secure-mitacs-accelerate-funding-to-study-the-therapeutic-effect-of-td-010-in-chronic-anxiety/)
- [BetterLife Receives Approval to Conduct COVID-19 Randomized Placebo-Controlled Trial with Pontificia Universidad Católica de Chile](https://abetterlifepharma.com/betterlife-receives-approval-to-conduct-covid-19-randomized-placebo-controlled-trial-with-pontificia-universidad-catolica-de-chile/)
- [BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) against Delta Variant of SARS-CoV-2](https://abetterlifepharma.com/betterlife-initiates-preclinical-study-of-ap-003-rhifna2b-against-delta-variant-of-sars-cov-2/)
- [BetterLife Enters Research Agreement with Medical College Wisconsin for TD-0148A Neurological Receptor Studies](https://abetterlifepharma.com/betterlife-enters-research-agreement-with-medical-college-wisconsin-for-td-0148a-neurological-receptor-studies/)
- [BetterLife to Present at the Emerging Growth Conference on September 15, 2021](https://abetterlifepharma.com/betterlife-to-present-at-the-emerging-growth-conference-on-september-15-2021/)
- [BetterLife Obtains TD-0148A Receptor Binding Data for  IND-Enabling Pharmacology Studies](https://abetterlifepharma.com/betterlife-obtains-td-0148a-receptor-binding-data-for-ind-enabling-pharmacology-studies-3/)
- [BetterLife Obtains TD-0148A Behavioural Pharmacology Data Confirming its Projected Non-hallucinogenic Property](https://abetterlifepharma.com/betterlife-obtains-td-0148a-behavioural-pharmacology-data-confirming-its-projected-non-hallucinogenic-property-2/)
- [BetterLife Successfully Completes Phase 1 and Initiates Phase 2 Clinical Trials with Interferon Alpha-2b in COVID-19 Patients in Chile](https://abetterlifepharma.com/betterlife-successfully-completes-phase-1-and-initiates-phase-2-clinical-trials-with-interferon-alpha-2b-in-covid-19-patients-in-chile/)
- [BetterLife Successfully Completes Phase 1 and Initiates Phase 2 Clinical Trials with Interferon Alpha-2b in COVID-19 Patients in Chile](https://abetterlifepharma.com/betterlife-successfully-completes-phase-1-and-initiates-phase-2-clinical-trials-with-interferon-alpha-2b-in-covid-19-patients-in-chile-2/)
- [BetterLife and Collaborators to Submit Key Joint Research Publication](https://abetterlifepharma.com/betterlife-and-collaborators-to-submit-key-joint-research-publication/)
- [BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model](https://abetterlifepharma.com/betterlife-lead-drug-betr-001-promotes-structural-neural-plasticity-in-preclinical-model/)
- [BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression](https://abetterlifepharma.com/betterlifes-betr-001-demonstrates-betr-001-anti-depressant-activity-in-preclinical-models-of-depression-2/)
- [BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference](https://abetterlifepharma.com/betterlife-to-present-betr-001-preclinical-data-at-the-upcoming-canadian-association-for-neuroscience-conference/)
- [BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) Forum](https://abetterlifepharma.com/betterlife-to-present-betr-001-preclinical-data-at-the-upcoming-federation-of-european-neuroscience-societies-fens-forum/)
- [BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference](https://abetterlifepharma.com/betterlife-to-participate-at-the-h-c-wainwright-1st-annual-mental-health-conference/)
- [BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies](https://abetterlifepharma.com/betterlife-secures-additional-mitacs-funding-in-collaboration-with-carleton-university-research-team-for-betr-001-preclinical-depression-studies/)
- [BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects](https://abetterlifepharma.com/betterlife-lead-drug-betr-001-promotes-structural-neural-plasticity-with-possible-nootropic-effects-similar-to-that-of-lsd-without-hallucinogenic-side-effects/)
- [BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives](https://abetterlifepharma.com/betterlife-files-comprehensive-patent-for-betr-001-and-other-lsd-derivatives/)
- [BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona](https://abetterlifepharma.com/betterlife-to-present-betr-001-preclinical-data-at-the-61st-annual-meeting-of-the-american-college-of-neuropsychopharmacology-acnp-in-phoenix-arizona/)
- [BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001](https://abetterlifepharma.com/betterlife-receives-fda-response-on-its-pre-ind-application-for-major-depressive-disorder-mdd-treatment-with-betr-001/)
- [BetterLife Announces Offering of Units](https://abetterlifepharma.com/betterlife-announces-offering-of-units/)
- [BetterLife Announces Closing of Private Placement](https://abetterlifepharma.com/betterlife-announces-closing-of-private-placement-2/)
- [BetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary of 2022 Accomplishments](https://abetterlifepharma.com/betterlife-announces-engagement-of-bloom-burton-securities-inc-and-provides-summary-of-2022-accomplishments/)
- [BetterLife Announces Pricing of Proposed Offering of Units](https://abetterlifepharma.com/betterlife-announces-pricing-of-proposed-offering-of-units/)
- [Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders.”](https://abetterlifepharma.com/betterlife-publishes-promising-results-from-a-study-titled-a-non-hallucinogenic-lsd-analog-with-therapeutic-potential-for-mood-disorders/)
- [BetterLife Closes $1,857,143 of Private Placement](https://abetterlifepharma.com/betterlife-closes-1857143-of-private-placement/)
- [CORRECTION - BetterLife Closes $1,857,143 of Private Placement](https://abetterlifepharma.com/correction-betterlife-closes-1857143-of-private-placement/)
- [Promise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article](https://abetterlifepharma.com/promise-of-betterlifes-non-hallucinogenic-lsd-betr-001-for-treating-mood-disorders-highlighted-in-medical-xpress-article/)
- [BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article](https://abetterlifepharma.com/betterlifes-non-hallucinogenic-lsd-betr-001-for-treating-mood-disorders-highlighted-in-drug-discovery-development-article/)
- [BetterLife Files Amended and Restated Offering Document for Offering of Units](https://abetterlifepharma.com/betterlife-files-amended-and-restated-offering-document-for-offering-of-units/)
- [BetterLife Pharma files site evidence package with Health Canada](https://abetterlifepharma.com/betterlife-pharma-files-site-evidence-package-with-health-canada-2/)
- [BetterLife Pharma files site evidence package with Health Canada](https://abetterlifepharma.com/betterlife-pharma-files-site-evidence-package-with-health-canada/)
- [BetterLife Pharma reicht Evidenzpaket für seine Anlage bei Health Canada ein](https://abetterlifepharma.com/betterlife-pharma-reicht-evidenzpaket-fur-seine-anlage-bei-health-canada-ein/)
- [BetterLife Pharma strengthen Board of Directors and Management](https://abetterlifepharma.com/betterlife-pharma-strengthen-board-of-directors-and-management/)
- [BetterLife Pharma strengthens Board of Directors and Management](https://abetterlifepharma.com/betterlife-pharma-strengthens-board-of-directors-and-management/)
- [BetterLife Pharma Acquires Swiss Based Solmic AG with Unique Global Patent for Production of New Generation CBD based Biopharmaceuticals](https://abetterlifepharma.com/betterlife-pharma-acquires-swiss-based-solmic-ag-with-unique-global-patent-for-production-of-new-generation-cbd-based-biopharmaceuticals-2/)
- [BetterLife Pharma Acquires Swiss Based Solmic AG with Unique Global Patent for Production of New Generation CBD based Biopharmaceuticals](https://abetterlifepharma.com/betterlife-pharma-acquires-swiss-based-solmic-ag-with-unique-global-patent-for-production-of-new-generation-cbd-based-biopharmaceuticals/)
- [BetterLife Pharma erwirbt die in der Schweiz ansässige Solmic AG mit einem einzigartigen, weltweiten Patent zur Produktion einer neuen Generation von auf CBD basierenden Biopharmazeutika](https://abetterlifepharma.com/betterlife-pharma-erwirbt-die-in-der-schweiz-ansassige-solmic-ag-mit-einem-einzigartigen-weltweiten-patent-zur-produktion-einer-neuen-generation-von-auf-cbd-basierenden-biopharmazeutika-2/)
- [BetterLife Pharma erwirbt die in der Schweiz ansässige Solmic AG mit einem einzigartigen, weltweiten Patent zur Produktion einer neuen Generation von auf CBD basierenden Biopharmazeutika](https://abetterlifepharma.com/betterlife-pharma-erwirbt-die-in-der-schweiz-ansassige-solmic-ag-mit-einem-einzigartigen-weltweiten-patent-zur-produktion-einer-neuen-generation-von-auf-cbd-basierenden-biopharmazeutika/)
- [BetterLife Pharma Provides Shareholder Update](https://abetterlifepharma.com/betterlife-pharma-provides-shareholder-update-3/)
- [BetterLife Pharma Provides Shareholder Update](https://abetterlifepharma.com/betterlife-pharma-provides-shareholder-update-2/)
- [BetterLife Pharma Enters into a Licensing Agreement](https://abetterlifepharma.com/betterlife-pharma-enters-into-a-licensing-agreement-2/)
- [BetterLife Pharma Enters into a Licensing Agreement](https://abetterlifepharma.com/betterlife-pharma-enters-into-a-licensing-agreement/)
- [BetterLife Pharma unterzeichnet Lizenzvereinbarung](https://abetterlifepharma.com/betterlife-pharma-unterzeichnet-lizenzvereinbarung/)
- [BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group](https://abetterlifepharma.com/betterlife-pharma-highlights-results-from-recent-clinical-reports-and-studies-on-use-of-interferon-and-announces-appointment-of-dr-mark-swaim-and-engagement-of-ir-group-2/)
- [BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group](https://abetterlifepharma.com/betterlife-pharma-highlights-results-from-recent-clinical-reports-and-studies-on-use-of-interferon-and-announces-appointment-of-dr-mark-swaim-and-engagement-of-ir-group/)
- [BetterLife Pharma meldet Ergebnisse von jüngsten klinischen Berichten und Studien hinsichtlich Anwendung von Interferon sowie Ernennung von Dr. Mark Swaim und Beauftragung einer IR-Gruppe](https://abetterlifepharma.com/betterlife-pharma-meldet-ergebnisse-von-jungsten-klinischen-berichten-und-studien-hinsichtlich-anwendung-von-interferon-sowie-ernennung-von-dr-mark-swaim-und-beauftragung-einer-ir-gruppe/)
- [BetterLife Pharma Confirms Re-Pricing of Warrants](https://abetterlifepharma.com/betterlife-pharma-confirms-re-pricing-of-warrants-2/)
- [BetterLife Pharma Confirms Re-Pricing of Warrants](https://abetterlifepharma.com/betterlife-pharma-confirms-re-pricing-of-warrants/)
- [BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19](https://abetterlifepharma.com/betterlife-pharma-announces-interferon-alpha-2b-covid-19-news-regarding-its-emergence-as-a-potential-treatment-for-covid-19-2/)
- [BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19](https://abetterlifepharma.com/betterlife-pharma-announces-interferon-alpha-2b-covid-19-news-regarding-its-emergence-as-a-potential-treatment-for-covid-19/)
- [BetterLife Pharma: Interferon Alpha-2b kommt als mögliche Behandlung für COVID-19 in Frage](https://abetterlifepharma.com/betterlife-pharma-interferon-alpha-2b-kommt-als-mogliche-behandlung-fur-covid-19-in-frage/)
- [BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon](https://abetterlifepharma.com/betterlife-pharma-announces-release-of-exploratory-study-on-treatment-of-covid-19-patients-in-wuhan-with-interferon-2/)
- [BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon](https://abetterlifepharma.com/betterlife-pharma-announces-release-of-exploratory-study-on-treatment-of-covid-19-patients-in-wuhan-with-interferon/)
- [BetterLife Pharma: Explorative Studie zur Behandlung von Patienten mit COVID-19 in Wuhan mit Interferon veröffentlicht](https://abetterlifepharma.com/betterlife-pharma-explorative-studie-zur-behandlung-von-patienten-mit-covid-19-in-wuhan-mit-interferon-veroffentlicht/)
- [BetterLife Pharma gibt die Bestellung von Dr. Eleanor Fish, einer führenden Expertin auf dem Gebiet der Interferonaktivität im Kampf gegen Covid-19, in seinen Beirat bekannt](https://abetterlifepharma.com/betterlife-pharma-gibt-die-bestellung-von-dr-eleanor-fish-einer-fuhrenden-expertin-auf-dem-gebiet-der-interferonaktivitat-im-kampf-gegen-covid-19-in-seinen-beirat-bekannt/)
- [BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board](https://abetterlifepharma.com/betterlife-pharma-announces-appointment-of-dr-eleanor-fish-a-leading-expert-on-interferon-activity-against-covid-19-to-its-advisory-board-2/)
- [BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board](https://abetterlifepharma.com/betterlife-pharma-announces-appointment-of-dr-eleanor-fish-a-leading-expert-on-interferon-activity-against-covid-19-to-its-advisory-board/)
- [BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum](https://abetterlifepharma.com/betterlife-pharma-secures-lock-up-agreements-from-shareholders-of-altum-2/)
- [BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum](https://abetterlifepharma.com/betterlife-pharma-secures-lock-up-agreements-from-shareholders-of-altum/)
- [BetterLife Pharma schließt mit Aktionären von Altum Lock-up-Vereinbarungen ab](https://abetterlifepharma.com/betterlife-pharma-schliest-mit-aktionaren-von-altum-lock-up-vereinbarungen-ab/)
- [BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum](https://abetterlifepharma.com/betterlife-pharma-updates-shareholders-on-its-proposed-acquisition-of-altum-4/)
- [BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum](https://abetterlifepharma.com/betterlife-pharma-updates-shareholders-on-its-proposed-acquisition-of-altum-3/)
- [BetterLife Pharma informiert seine Aktionäre über die geplante Übernahme von Altum](https://abetterlifepharma.com/betterlife-pharma-informiert-seine-aktionare-uber-die-geplante-ubernahme-von-altum-2/)
- [BetterLife Pharma Announces OTC Trading Symbol Change to “BETRF” Effective June 9, 2020](https://abetterlifepharma.com/betterlife-pharma-announces-otc-trading-symbol-change-to-betrf-effective-june-9-2020-2/)
- [BetterLife Pharma Announces OTC Trading Symbol Change to “BETRF” Effective June 9, 2020](https://abetterlifepharma.com/betterlife-pharma-announces-otc-trading-symbol-change-to-betrf-effective-june-9-2020/)
- [BetterLife Pharma kündigt die Änderung des OTC-Handelssymbols in "BETRF" mit Wirkung ab 9. Juni 2020 an](https://abetterlifepharma.com/betterlife-pharma-kundigt-die-anderung-des-otc-handelssymbols-in-betrf-mit-wirkung-ab-9-juni-2020-an/)
- [BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum](https://abetterlifepharma.com/betterlife-pharma-updates-shareholders-on-its-proposed-acquisition-of-altum-2/)
- [BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum](https://abetterlifepharma.com/betterlife-pharma-updates-shareholders-on-its-proposed-acquisition-of-altum/)
- [BetterLife Pharma informiert seine Aktionäre über die geplante Übernahme von Altum](https://abetterlifepharma.com/betterlife-pharma-informiert-seine-aktionare-uber-die-geplante-ubernahme-von-altum/)
- [BetterLife Pharma Announces Consolidation of its Common Shares](https://abetterlifepharma.com/betterlife-pharma-announces-consolidation-of-its-common-shares-2/)
- [BetterLife Pharma Announces Consolidation of its Common Shares](https://abetterlifepharma.com/betterlife-pharma-announces-consolidation-of-its-common-shares/)
- [BetterLife Pharma gibt Zusammenlegung seiner Stammaktien bekannt](https://abetterlifepharma.com/betterlife-pharma-gibt-zusammenlegung-seiner-stammaktien-bekannt/)
- [BetterLife Pharma Launches Website](https://abetterlifepharma.com/betterlife-pharma-launches-website/)
- [Interferon Treatment Trial 'a Major Breakthrough' Against the Pandemic](https://abetterlifepharma.com/interferon-treatment-trial-a-major-breakthrough-against-the-pandemic/)
- [BetterLife Pharma issues update on its promotional activity](https://abetterlifepharma.com/betterlife-pharma-issues-update-on-its-promotional-activity/)
- [BetterLife Pharma Provides Update on Proposed Acquisition of Altum and its Regulatory Guidance and Updated Clinical Development Plan](https://abetterlifepharma.com/betterlife-pharma-provides-update-on-proposed-acquisition-of-altum-and-its-regulatory-guidance-and-updated-clinical-development-plan-2/)
- [BetterLife Pharma Provides Update on Proposed Acquisition of Altum and its Regulatory Guidance and Updated Clinical Development Plan](https://abetterlifepharma.com/betterlife-pharma-provides-update-on-proposed-acquisition-of-altum-and-its-regulatory-guidance-and-updated-clinical-development-plan/)
- [BetterLife Pharma informiert über die geplante Übernahme von Altum, die behördlichen Richtlinien und den neuen klinischen Entwicklungsplan](https://abetterlifepharma.com/betterlife-pharma-informiert-uber-die-geplante-ubernahme-von-altum-die-behordlichen-richtlinien-und-den-neuen-klinischen-entwicklungsplan/)
- [BetterLife Pharma Receives Approval from Altum Pharmaceuticals Inc. Shareholders to Complete Merger](https://abetterlifepharma.com/betterlife-pharma-receives-approval-from-altum-pharmaceuticals-inc-shareholders-to-complete-merger/)
- [BetterLife Announces Trading Halt of its Shares on the Canadian Stock Exchange Following Merger Announcement](https://abetterlifepharma.com/betterlife-announces-trading-halt-of-its-shares-on-the-canadian-stock-exchange-following-merger-announcement/)
- [BetterLife Provides Update on OTC Trading Activity](https://abetterlifepharma.com/betterlife-provides-update-on-otc-trading-activity/)
- [BetterLife Announces VirTrial as Clinical Trial Patient Monitoring Partner](https://abetterlifepharma.com/betterlife-announces-virtrial-as-clinical-trial-patient-monitoring-partner-2/)
- [BetterLife Names CRO for COVID-19 Clinical Trial in Australia](https://abetterlifepharma.com/betterlife-names-cro-for-covid-19-clinical-trial-in-australia/)
- [BetterLife adds Next-Gen Psychedelic Therapy to its Pipeline of Drugs](https://abetterlifepharma.com/betterlife-adds-next-gen-psychedelic-therapy-to-its-pipeline-of-drugs/)
- [BetterLife fügt seiner Liste von Arzneimittelkandidaten ein Psychotherapeutikum der nächsten Generation hinzu](https://abetterlifepharma.com/betterlife-fugt-seiner-liste-von-arzneimittelkandidaten-ein-psychotherapeutikum-der-nachsten-generation-hinzu/)
- [BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application](https://abetterlifepharma.com/betterlifes-recent-acquisition-taking-lsd-from-experimental-to-a-major-therapeutic-application/)
- [BetterLifes Neuerwerb: LSD avanciert vom Studienstatus zur wichtigen therapeutischen Anwendung](https://abetterlifepharma.com/betterlifes-neuerwerb-lsd-avanciert-vom-studienstatus-zur-wichtigen-therapeutischen-anwendung/)
- [BetterLife erwirbt zweite Generation von Psychedelika-Aktiva von Transcend Biodynamics LLC](https://abetterlifepharma.com/betterlife-erwirbt-zweite-generation-von-psychedelika-aktiva-von-transcend-biodynamics-llc/)
- [BetterLife begrüßt führende Experten der Psychedelikabranche in seinem Führungsteam](https://abetterlifepharma.com/betterlife-begrust-fuhrende-experten-der-psychedelikabranche-in-seinem-fuhrungsteam/)
- [BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team](https://abetterlifepharma.com/betterlife-welcomes-psychedelic-industry-leaders-to-the-senior-management-team-2/)
- [BetterLife Pharma verstärkt Board of Directors](https://abetterlifepharma.com/betterlife-pharma-verstarkt-board-of-directors/)
- [BetterLife Pharma Strengthens Board of Directors](https://abetterlifepharma.com/betterlife-pharma-strengthens-board-of-directors/)
- [BetterLife Pharma: Invitation to the Benzinga Global Small Cap Conference](https://abetterlifepharma.com/betterlife-pharma-invitation-to-the-benzinga-global-small-cap-conference/)
- [Dr. Eleanor Fish, Advisory Board Member, Awarded Order of Canada](https://abetterlifepharma.com/dr-eleanor-fish-advisory-board-member-awarded-order-of-canada/)
- [Psychedelic Therapy Without the Hallucinations: Interview with BetterLife Pharma](https://abetterlifepharma.com/psychedelic-therapy-without-the-hallucinations-interview-with-betterlife-pharma-3/)
- [BetterLife Resumes Trading Following CSE Merger Ratification with Altum Pharmaceuticals](https://abetterlifepharma.com/betterlife-resumes-trading-following-cse-merger-ratification-with-altum-pharmaceuticals/)
- [BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC](https://abetterlifepharma.com/betterlife-closes-acquisition-of-second-generation-psychedelic-assets-of-transcend-biodynamics-llc-4/)
- [Pre-IND Discussion with U.S. FDA Helps BetterLife Set Up AP-003 Clinical Trials in Australia](https://abetterlifepharma.com/pre-ind-discussion-with-u-s-fda-helps-betterlife-set-up-ap-003-clinical-trials-in-australia/)
- [BetterLife Pharma Signs eTMF Partner to Help Accelerate AP-003 Clinical Trial Operations](https://abetterlifepharma.com/betterlife-pharma-signs-etmf-partner-to-help-accelerate-ap-003-clinical-trial-operations/)
- [BetterLife Provides Important Update on its Australian Clinical Study Design](https://abetterlifepharma.com/betterlife-provides-important-update-on-its-australian-clinical-study-design/)
- [BETTERLIFE PHARMA ANNOUNCES UP TO $5.0 MILLION PRIVATE PLACEMENT OFFERING OF SPECIAL WARRANTS](https://abetterlifepharma.com/betterlife-pharma-announces-up-to-5-0-million-private-placement-offering-of-special-warrants/)
- [BetterLife Receives FINRA Approval and Resumes Trading on the OTC Markets](https://abetterlifepharma.com/betterlife-receives-finra-approval-and-resumes-trading-on-the-otc-markets/)
- [BetterLife Scales up Manufacturing of AP-003 (Interferon Alpha 2b) to Prepare for Clinical Trials](https://abetterlifepharma.com/betterlife-scales-up-manufacturing-of-ap-003-interferon-alpha-2b-to-prepare-for-clinical-trials/)
- [BetterLife CEO Interview on Canadian Stock Exchange Podcast Discussing Recent Advancements Now Live](https://abetterlifepharma.com/betterlife-ceo-interview-on-canadian-stock-exchange-podcast-discussing-recent-advancements-now-live/)
- [BetterLife Pharma Engages Hybrid Financial Ltd.](https://abetterlifepharma.com/betterlife-pharma-engages-hybrid-financial-ltd/)
- [BetterLife Pharma Announces Dr. Eleanor Fish to Retain Role as Key Scientific Advisor Following Invitation to Join Government COVID-19 Task Force](https://abetterlifepharma.com/betterlife-pharma-announces-dr-eleanor-fish-to-retain-role-as-key-scientific-advisor-following-invitation-to-join-government-covid-19-task-force/)
- [BetterLife Announces Closing of Private Placement](https://abetterlifepharma.com/betterlife-announces-closing-of-private-placement/)
- [BETTERLIFE PHARMA ANNOUNCES CLOSING OF $2.9 MILLION PRIVATE PLACEMENT OFFERING](https://abetterlifepharma.com/betterlife-pharma-announces-closing-of-2-9-million-private-placement-offering/)
- [BetterLife’s Wholly-Owned Subsidiary, Altum Pharmaceuticals, Obtains Non-Dilutive Financing Commitment From Strategic Investor!](https://abetterlifepharma.com/betterlifes-wholly-owned-subsidiary-altum-pharmaceuticals-obtains-non-dilutive-financing-commitment-from-strategic-investor/)
- [BetterLife Obtains Positive TD-0148A Data in Preclinical Models of Depression](https://abetterlifepharma.com/betterlife-obtains-positive-td-0148a-data-in-preclinical-models-of-depression/)
- [H.C. Wainwright 2nd Annual Psychedelics Conference, BACK TO THE FUTURE!](https://abetterlifepharma.com/h-c-wainwright-2nd-annual-psychedelics-conference-back-to-the-future/)
- [Developing Psychedelic Medicine Beyond What We Already Know!](https://abetterlifepharma.com/developing-psychedelic-medicine-beyond-what-we-already-know/)
- [BetterLife Obtains TD-0148A In Vitro Pharmacology Data Confirming its Activity in Key Receptors Implicated in Depression and Neuropathic Pain](https://abetterlifepharma.com/betterlife-obtains-td-0148a-in-vitro-pharmacology-data-confirming-its-activity-in-key-receptors-implicated-in-depression-and-neuropathic-pain/)
- [Early Results of BetterLife Preclinical Study Show AP-003 (rhIFN⍺2b) Provides Up to 97% Protection in Human Cells Against the Delta Variant of SARS-CoV-2](https://abetterlifepharma.com/early-results-of-betterlife-preclinical-study-show-ap-003-rhifn⍺2b-provides-up-to-97-protection-in-human-cells-against-the-delta-variant-of-sars-cov-2/)
- [BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders](https://abetterlifepharma.com/betterlife-files-patent-for-td-0148a-for-treatment-of-cluster-headaches-and-related-disorders/)
- [BetterLife Enrolls First Patient in Interferon alpha-2b COVID-19 Trial in Chile](https://abetterlifepharma.com/betterlife-enrolls-first-patient-in-interferon-alpha-2b-covid-19-trial-in-chile/)
- [BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board](https://abetterlifepharma.com/betterlife-announces-formation-of-next-generation-psychedelic-research-advisory-board/)
- [BetterLife Pharma's new acquisition takes LSD from being experimental to a major therapeutic application](https://abetterlifepharma.com/betterlife-pharmas-new-acquisition-takes-lsd-from-being-experimental-to-a-major-therapeutic-application/)

## Pages

- [Home](https://abetterlifepharma.com/) - To give you the normal healthy life you should have. Revolutionizing Brain Health BetterLife Pharma is an emerging biotechnology company focused on developing and commercializing patient-friendly compounds to treat neuro-psychiatric and neurological disorders. Our vision is to take the fear out of psychedelics by producing non-hallucinogenic medicines that will be the solutions to treat the
- [BETR-001](https://abetterlifepharma.com/betr-001/) - BETR-001 BETR-001 is a BetterLife patent protected derivative of lysergic acid diethylamide (LSD). BETR-001 is a potent neuroplastogen but is non-hallucinogenic. BETR-001 enables the brain to rewire, repair and heal itself. BETR-001 has all the therapeutic benefits of psychedelics without hallucinations and without controlled substance restrictions. Compound Code: BETR-001 Delivery: Oral capsules Potential Indications: Traumatic
- [Our Approach](https://abetterlifepharma.com/our-approach/) - Our Approach Revolutionizing Brain Health BetterLife is developing non-hallucinogenic psychedelic derived compounds that can repair, rewire and heal the brain. The New Paradigm and its Challenges Psychedelics have emerged as a new paradigm in treatment of neurological and psychiatric disorders. A key property of psychedelics is their neuroplastogenic activity. A neuroplastogen is a compound that
- [Contact](https://abetterlifepharma.com/contact/) - Working together to Build a BetterLife, for all. Our work delivers patient-friendly medicines to rejuvenate and restore the health of the mind and the body, for all. Your name* Your Email* Subject* Message* CAPTCHA Head Office: 1275 West 6th Avenue, # 300Vancouver, BC V6H 1A6Canada Investor Relations: ir@blifepharma.com INVESTOR OVERVIEW BetterLife Investor Presentation read more
- [Investor Relations](https://abetterlifepharma.com/investor-relations/) - News Stock Quote & Chart Filings Investor Overview BetterLife is an emerging biotech company creating and clinically validating 2nd-Generation Non-Hallucinogenic Psychedelic compounds and drug delivery mechanisms for clinical trials and commercialization of cutting-edge treatments for mental disorders. CSE: BETR OTCQB: BETRF FRA: NPAU Corporate Summary As an emerging biotech company, focused on the development and
- [About Us](https://abetterlifepharma.com/about-us/) - OUR LEADERSHIP … is focused on developing breakthrough treatments that will repair, rewire and heal the brain. OUR MANAGEMENT TEAM Ahmad Doroudian, PhD Chief Executive Officer & Director 20+ years experience as a Pharma CEO in finance, including M&A, and multiple IPOs, integration of pharmaceutical operations (Whitehall Robbins, Rhone Polenc, Boehringer, Aventis) Founder of Merus
- [News](https://abetterlifepharma.com/news/) - News BetterLife has assembled a highly experienced management team that hasclinical, commercial, product development and financial experience all tantamount to deliver meaningful communication to patients, investors, shareholders, and stakeholders. Press Release Search for: December 4, 2025 BetterLife Pharma Highlights Advantages of BETR-001 – a Potent Neuroplastogen November 25, 2025 BetterLife Pharma Welcomes Daniel Carcillo as
- [Investor Relations New](https://abetterlifepharma.com/investor-relations-new/) - News Stock Quote & Chart Filings Investor Overview BetterLife is an emerging biotech company creating and clinically validating 2nd-Generation Non-Hallucinogenic Psychedelic compounds and drug delivery mechanisms for clinical trials and commercialization of cutting-edge treatments for mental disorders. CSE: BETR OTCQB: BETRF FRA: NPAU Corporate Summary As an emerging biotech company, focused on the development and
- [Pipeline](https://abetterlifepharma.com/pipeline/) - BetterLife Pharma is an emerging biotechnology company focused on developing and commercializing patient-friendly compounds to treat psychiatric and neurological disorders. Our vision is to develop breakthrough non-hallucinogenic psychedelic derivatives with the therapeutic potential to treat wide range of mental health and neurological conditions that have a high unmet need. Burdens call for alternatives in the
- [Anxiety Disorder](https://abetterlifepharma.com/anxiety-disorder/) - MDD AD Nep BZD Terminology Anxiety Disorder (AD) Anxiety does not empty tomorrow of its sorrows, but only empties today of its strength. Charles Spurgeon The Condition: A class of drugs used to slow the brain activity through the use of a sedative or tranquilizer. Designed to treat symptoms of anxiety, panic disorders, insomnia, muscle
- [Terminology](https://abetterlifepharma.com/terminology/) - MDD AD Nep BZD Terminology 2-Bromo-LSD A derivative of LSD (or LSD-25) where at its 2-position carbon atom a bromine atom is added. The first published report of synthesis of one form of 2-bromo-LSD is by Franz Troxler & Albert Hofmann in 1957, while they were working at the Sandoz laboratories in Basel, Switzerland. Albert
- [Investor Relations test](https://abetterlifepharma.com/investor-relations-test/) - News Stock Quote & Chart Filings Investor Overview BetterLife is an emerging biotech company creating and clinically validating 2nd-Generation Non-Hallucinogenic Psychedelic compounds and drug delivery mechanisms for clinical trials and commercialization of cutting-edge treatments for mental disorders. CSE: BETR OTCQB: BETRF FRA: NPAU Corporate Summary As an emerging biotech company, focused on the development and
- [Indications Nep](https://abetterlifepharma.com/indications-nep/) - MDD AD Nep BZD Terminology Neuropathic Pain (NeP) Chronic pain is not all about the body, and it’s not all about the brain – it’s everything. Target everything. Take back your life Sean MacKey, MD, PhD The Condition: Pain-sensing nerves have been damaged, irritated, or altered the nervous system misfiring a pain signal Neuropathies
- [Indications trd](https://abetterlifepharma.com/indications-trd/) - MDD AD Nep BZD Terminology Treatment Resistance Disorder (TRD) Months or even years can go by without any relief. And after the effort it took to get help, it can be demoralizing when you’re just not getting better. Dr. Debra Fulghum Bruce The Condition: Onset of depression when a patient has not responded to consecutive
- [Indications ch](https://abetterlifepharma.com/indications-ch/) - MDD AD Nep BZD Terminology Cluster Headaches (CH) Cluster headaches have attacked me for 12 years now. I fight the monster everyday. Anonymous The Condition: Extremely intense headaches; short attacks range 15-180 mins; and can have several episodes in a day. Affect men most often than women. Can come on with no warning, feel very
- [Indications ptsd](https://abetterlifepharma.com/indications-ptsd/) - MDD AD Nep BZD Terminology Post-Traumatic Stress Disorder (PTSD) It’s not the person refusing to let go of the past, but the past refusing to let go of the person. Unknown The Condition: A psychiatric disorder that people have after experiencing/witnessing a traumatic event in their life. Example trigger events can be death, injury, accident,
- [Indications bzd](https://abetterlifepharma.com/indications-bzd/) - MDD AD Nep BZD Terminology Benzodiazepine (BZD) Dependency It is more difficult to withdraw people from benzodiazepines than it is from heroin. Professor Malcom Lader The Condition: A class of drugs used to slow the brain activity through the use of a sedative or tranquilizer. Designed to treat symptoms of anxiety, panic disorders, insomnia, muscle
- [Indications mdd](https://abetterlifepharma.com/indications-mdd/) - MDD AD Nep BZD Terminology Major Depressive Disorder (MDD) Depression is the constant feeling of being numb. It’s being numb to emotions, being numb to life. Youth Dynamics The Condition: A mental disorder characterized by a sustained feeling of sadness or loss of pleasure and or interest in life. Can include changes in sleep, energy,
- [Test](https://abetterlifepharma.com/test/) - Item 1 Over 30 Million User in The US Item 2 Present your content in an attractive Circle layout item 2. You can highlight key information with click or hover effects and style it as per your preference. Item 3 Present your content in an attractive Circle layout item 3. You can highlight key information
- [Stock Quote & Chart](https://abetterlifepharma.com/stock-quote-chart/) - Stock Quote & Chart Contact Us Working together to Build a BetterLife for all. REACH US INVESTOR OVERVIEW BetterLife Investor Presentation read more
- [Test Page](https://abetterlifepharma.com/test-page/) - BetterLife Announces Closing of Private Placement Read More BetterLife Pharma Engages Hybrid Financial Ltd. Read More BetterLife Pharma Announces Dr. Eleanor Fish to Retain Role as Key Scientific Advisor Following Invitation to Join Government COVID-19 Task Force Read More BetterLife Resumes Trading Following CSE Merger Ratification with Altum Pharmaceuticals Read More Load More
- [Media & Events](https://abetterlifepharma.com/media-events/) - Media & Events Delivering innovative, patient-friendly solutions is BetterLife’s passion. This long-term value generating commitment is the uniqueness needed for the marketplace. BetterLife’s responsibility is sharing it with credibility, integrity, and authority. Media & Events Search for: Conferences Media Multimedia December 9, 2021 The FDA and Psychedelics – Where Are We Today November 19, 2021 PTSF85 –
- [Risk Factors and Cautionary Note](https://abetterlifepharma.com/risk-factors-and-cautionary-note/) - Risk Factors and Cautionary Note This website contains statistical data, market research, website links, third party publications and industry forecasts that were obtained from government or other third party publications and reports or based on estimates derived from such publications and reports and management’s knowledge of, and experience in, the markets in which the Corporation
- [Conferences & Presentation](https://abetterlifepharma.com/conferences-presentation/) - Conferences & Presentation BetterLife has assembled a highly experienced management team that has clinical, commercial, product development and financial experience Conferences & Presentation Search for: December 9, 2021 The FDA and Psychedelics – Where Are We Today Read More November 19, 2021 PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid Nazeer of
- [Stock Info](https://abetterlifepharma.com/stock-info/) - News Stock Quote & Chart Filings Investor Overview BetterLife an emerging bio-tech company creating and clinically validating an evolving intellectual property portfolio of novel molecules and drug delivery mechanisms for clinical trials and commercialization of cutting-edge treatments for mental disorders. Download our Investor Presentation Download our Enterprise Report CSE: BETR OTCQB: BETRF FRA: NPAU Our
- [Pipeline Backup](https://abetterlifepharma.com/pipeline-backup/) - PIPELINE OVERVIEW BetterLife’s drug candidates include four compelling and differentiated assets. SECOND GENERATION PSYCHEDELICS AREA: Depression PRODUCT: BETR-001 INDICATION: Major depressive disorder (MDD) STATUS: Pre-clinical DISCOVERY PRE-CLINICAL DISCOVERY PRE-CLINICAL 98% IND IND 10% PHASE 1 PHASE 1 50% PHASE 2 PHASE 2 50% PHASE 3 PHASE 3 50% NOVEL NEURO-PHARMACOLOGICAL COMPOUNDS AREA: Anxiety PRODUCT: BETR-002
- [Our Services](https://abetterlifepharma.com/our-services/) - Diagnosis Bronchoscopy Parathyroid Scan Orthotics Captopril Renography Full Blood Count Head CT Mammography Therapy Healthy Teeth Non-invasive Orthotics Full Body MRI Scan Lab Tests Laboratory Tests Test Analysis Blood Tests Etiam pellt esque maut arcu tempus, ad digs, consr a lorem ipsum maxieget. Angela Adams Cardiac Surgery Our next level of care Lorem ipsum dolor
- [Our Staff](https://abetterlifepharma.com/our-staff/) - No posts were found for provided query parameters.

## My Templates

- [About Us](https://abetterlifepharma.com/?elementor_library=about-us) - OUR LEADERSHIP … is focused on developing breakthrough treatments that will repair, rewire and heal the brain. OUR MANAGEMENT TEAM Ahmad Doroudian, PhD Chief Executive Officer & Director 20+ years experience as a Pharma CEO in finance, including M&A, and multiple IPOs, integration of pharmaceutical operations (Whitehall Robbins, Rhone Polenc, Boehringer, Aventis) Founder of Merus
- [Our Approach](https://abetterlifepharma.com/?elementor_library=our-approach) - Our Approach Revolutionizing Brain Health BetterLife is developing non-hallucinogenic psychedelic derived compounds that can repair, rewire and heal the brain. The New Paradigm and it Challenges Psychedelics have emerged as a new paradigm in treatment of neurological and psychiatric disorders. A key property of psychedelics is their neuroplastogenic activity. A neuroplastogen is a compound that
- [BETR-001](https://abetterlifepharma.com/?elementor_library=betr-001) - BETR-001 BETR-001 is a BetterLife patent protected derivative of lysergic acid diethylamide (LSD). BETR-001 is a potent neuroplaastogen but is non-hallucinogenic. BETR-001 enables the brain to rewire, repair and heal itself. BETR-001 has all the therapeutic benefits of psychedelics without hallucinations and without controlled substance restrictions. Compound Code: BETR-001 Delivery: Oral, Capsule Indications: Traumatic Brain
- [Multimedia Section](https://abetterlifepharma.com/?elementor_library=multimedia-section) - April 6, 2022 BetterLife Pharma able to demonstrate BETR-001 Anti-Depressant activity in Preclinical Models March 16, 2022 BetterLife Pharma says it has confirmed bioavailability of BETR-001 compound in pre-clinical study March 16, 2022 BetterLife Pharma says it has confirmed bioavailability of BETR-001 compound in pre-clinical study January 20, 2022 BetterLife Pharma receives response from U.S.
- [Media Section](https://abetterlifepharma.com/?elementor_library=media-section) - March 13, 2024 This Biotech Is a Potential Disruptor, Expert Says March 6, 2024 NEW RECOMMENDATION – BETTER LIFE PHARMA (CSE-BETR; OTCQB-BETRF) February 14, 2024 Beyond the Magic of Mushrooms: Using Psychedelic Derivatives to Treat Depression September 11, 2023 Exploring the LSD-Derivative With Potential for Treating Mood Disorders August 14, 2023 Biotech Innovations: Advancing Mental
- [Conferences Section](https://abetterlifepharma.com/?elementor_library=conferences-section) - December 9, 2021 The FDA and Psychedelics – Where Are We Today November 19, 2021 PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid Nazeer of Wesana Health November 18, 2021 Non Hallucinogenic LSD? BetterLife Pharma on Psychedelic Investors Radar October 29, 2021 BetterLife Pharma: Non-Hallucinogenic, Patient-Friendly Medicines|Benzinga Small Cap Conference 2021 October
- [Search Results](https://abetterlifepharma.com/?elementor_library=elementor-archive-18843) - December 4, 2025 BetterLife Pharma Highlights Advantages of BETR-001 – a Potent Neuroplastogen November 25, 2025 BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor October 21, 2025 BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor June 18, 2025 USPTO Files ISSUE NOTIFICATION for BetterLife’s BETR-001 Composition of Matter Patent May 28, 2025 BetterLife Pharma Provides
- [Blog Grid](https://abetterlifepharma.com/?elementor_library=elementor-loop-18567) - January 25, 2022 Blog Grid Read More
- [Elementor Loop #18270](https://abetterlifepharma.com/?elementor_library=elementor-loop-18270) - January 21, 2022 Elementor Loop #18270
- [Elementor Archive #18332](https://abetterlifepharma.com/?elementor_library=elementor-archive-18332) - Template: Elementor Archive #18332 December 4, 2025 BetterLife Pharma Highlights Advantages of BETR-001 – a Potent Neuroplastogen November 25, 2025 BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor October 21, 2025 BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor June 18, 2025 USPTO Files ISSUE NOTIFICATION for BetterLife’s BETR-001 Composition of Matter Patent May 28,
- [Elementor Archive #18265](https://abetterlifepharma.com/?elementor_library=elementor-archive-18265) - Search Search December 4, 2025 BetterLife Pharma Highlights Advantages of BETR-001 – a Potent Neuroplastogen November 25, 2025 BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor October 21, 2025 BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor June 18, 2025 USPTO Files ISSUE NOTIFICATION for BetterLife’s BETR-001 Composition of Matter Patent May 28, 2025 BetterLife
- [Press Release Section](https://abetterlifepharma.com/?elementor_library=press-release-section)
- [Media & News Section](https://abetterlifepharma.com/?elementor_library=media-news-section) - Media & Events Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 – Form 6-K November 29, 2021 Read More Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 – Form 6-K November 28, 2021 Read More
- [Box Section](https://abetterlifepharma.com/?elementor_library=box-section) - Burdens call for alternatives in the landscape of options …. Societal strains, are alarming & intensifying calling for alternatives! People Are struggling with increased occurrences of mental health issues Providers Are challenged to keep pace with higher demands for better solutions Systems Are stained at length from pressures due to increasing number of conditions Goverment
- [INVESTOR OVERVIEW](https://abetterlifepharma.com/?elementor_library=investor-overview) - INVESTOR OVERVIEW BetterLife Investor Presentation read more
- [Blog List](https://abetterlifepharma.com/?elementor_library=blog-list) - No posts were found for provided query parameters.
- [OUR LEADERSHIP TEAM](https://abetterlifepharma.com/?elementor_library=our-leadership-team) - OUR LEADERSHIP TEAM BetterLife has assembled a highly experienced management team that has clinical, commercial, product development and financial experience Explore More
- [Page Banner](https://abetterlifepharma.com/?elementor_library=page-banner) - Get in touch with us BetterLife has assembled a highly experienced management team that has clinical, commercial, product development and financial experience
- [Default Kit](https://abetterlifepharma.com/?elementor_library=default-kit)
- [home-4-content](https://abetterlifepharma.com/?elementor_library=home-4-content) - We are official provider of: Best healthcare 20 years of work Multiple locations Worldwide offices Success in Courts 1265 cases won Testing labs 69 new formulas Best healthcare 20 years of work Multiple locations Worldwide offices Success in Courts 1265 cases won Testing labs 69 new formulas
- [section w/ pic](https://abetterlifepharma.com/?elementor_library=section-w-pic) - The services we provide Nullam erat lectus, ullamcorper sed finibus ut. Vulputate porttitor diam, iaculis neque sed enim amet efficitur lorem ipsum lectus sit amet. Phasellus vel hendrerit erat. Quisque euismod interdum cond estibulum ante ipsm primis in faucibus orci luctus et ultrice cubilia curae; Nullam placerat leo mauris, lacinia pulvinar, runc iduntfaucibus orci sodales
- [icon w/ text](https://abetterlifepharma.com/?elementor_library=icon-w-text) - Our next level of care Lorem ipsum dolor sit amet, consectetur adipiscing elit. In posuere interdum nunc eget, gravida nibh convallis at. Care that goes beyond Nunc interdum sapien ut mauris maximus, consectetur porta nunc. Convallis lorem ipsum dolor sit amet. Aonsectetur adipiscing elit in suere interdum nunc eget. Your health and wellness Sed dui
- [team content](https://abetterlifepharma.com/?elementor_library=team-content) - Exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo. Non habent claritatem in sitamconquat duis autem facilisis at vero eros nibh. Euismod tincidunt ut laoreet vel eum iriure qui sequitur mutatioconsuetudi um. Lectorum mirum est notare uis autem vel eum iriure dolor in. Hendrerit in vulputate velit essemolestie consequat, vel illum. Dolore eu
- [inner main](https://abetterlifepharma.com/?elementor_library=inner-main) - 3 doctors 4 specialists 7 nurses
- [Icon With Text](https://abetterlifepharma.com/?elementor_library=icon-with-text) - Our next level of care Lorem ipsum dolor sit amet, consectetur adipiscing elit. In posuere interdum nunc eget, gravida nibh convallis at. Care that goes beyond Nunc interdum sapien ut mauris maximus, consectetur porta nunc. Convallis lorem ipsum dolor sit amet. Aonsectetur adipiscing elit in suere interdum nunc eget. Your health and wellness Sed dui
- [Default Kit](https://abetterlifepharma.com/?elementor_library=default-kit-2)

## ProMedica Team

- [Wolfgang Renz, MD](https://abetterlifepharma.com/team/wolfgang-renz/)
- [Henri Sant-Cassia](https://abetterlifepharma.com/team/henri-sant-cassia/)
- [Ralph Anthony Pullen](https://abetterlifepharma.com/team/ralph-anthony-pullen/)
- [Robert Metcalfe](https://abetterlifepharma.com/team/robert-metcalfe/)
- [Ahmad Doroudian, PhD](https://abetterlifepharma.com/team/ahmad-doroudian-phd/)

## Media & Events

- [This Biotech Is a Potential Disruptor, Expert Says](https://abetterlifepharma.com/media_events/this-biotech-is-a-potential-disruptor-expert-says/)
- [Beyond the Magic of Mushrooms: Using Psychedelic Derivatives to Treat Depression](https://abetterlifepharma.com/media_events/beyond-the-magic-of-mushrooms-using-psychedelic-derivatives-to-treat-depression/)
- [NEW RECOMMENDATION – BETTER LIFE PHARMA (CSE-BETR; OTCQB-BETRF)](https://abetterlifepharma.com/media_events/new-recommendation-better-life-pharma-cse-betr-otcqb-betrf/)
- [Exploring the LSD-Derivative With Potential for Treating Mood Disorders](https://abetterlifepharma.com/media_events/exploring-the-lsd-derivative-with-potential-for-treating-mood-disorders/)
- [Biotech Innovations: Advancing Mental Health with Contemporary Non-Hallucinogenic Psychedelic Compounds](https://abetterlifepharma.com/media_events/biotech-innovations-advancing-mental-health-with-contemporary-non-hallucinogenic-psychedelic-compounds/)
- [Transcend Biodynamics](https://abetterlifepharma.com/media_events/transcend-biodynamics/)
- [Psychedelics Unshackled by BioTech Innovators at BetterLife Pharma](https://abetterlifepharma.com/media_events/psychedelics-unshackled-by-biotech-innovators-at-betterlife-pharma/)
- [BetterLife Pharma able to demonstrate BETR-001 Anti-Depressant activity in Preclinical Models](https://abetterlifepharma.com/media_events/betterlife-pharma-able-to-demonstrate-betr-001-anti-depressant-activity-in-preclinical-models/)
- [BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression](https://abetterlifepharma.com/media_events/betterlifes-betr-001-demonstrates-betr-001-anti-depressant-activity-in-preclinical-models-of-depression-2/)
- [BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression](https://abetterlifepharma.com/media_events/betterlifes-betr-001-demonstrates-betr-001-anti-depressant-activity-in-preclinical-models-of-depression/)
- [BetterLife Pharma says it has confirmed bioavailability of BETR-001 compound in pre-clinical study](https://abetterlifepharma.com/media_events/betterlife-pharma-says-it-has-confirmed-bioavailability-of-betr-001-compound-in-pre-clinical-study/)
- [BetterLife Pharma says preclinical data has confirmed bioavailability of BETR-001](https://abetterlifepharma.com/media_events/betterlife-pharma-says-preclinical-data-has-confirmed-bioavailability-of-betr-001/)
- [The promise of psychedelic research](https://abetterlifepharma.com/media_events/the-promise-of-psychedelic-research/)
- [Neuroplasticity, Psychedelics, and Mental Health](https://abetterlifepharma.com/media_events/neuroplasticity-psychedelics-and-mental-health-2/)
- [Neuroplasticity, Psychedelics, and Mental Health](https://abetterlifepharma.com/media_events/neuroplasticity-psychedelics-and-mental-health/)
- [BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model](https://abetterlifepharma.com/media_events/betterlife-lead-drug-betr-001-promotes-structural-neural-plasticity-in-preclinical-model/)
- [BetterLife Pharma says LSD analog BETR-001 promotes structural neural plasticity in preclinical model](https://abetterlifepharma.com/media_events/betterlife-pharma-says-lsd-analog-betr-001-promotes-structural-neural-plasticity-in-preclinical-model/)
- [BetterLife Pharma launches its new corporate website](https://abetterlifepharma.com/media_events/betterlife-pharma-launches-its-new-corporate-website/)
- [BetterLife Launches New Corporate Website](https://abetterlifepharma.com/media_events/betterlife-launches-new-corporate-website/)
- [Psychedelics Stocks to Watch](https://abetterlifepharma.com/media_events/psychedelics-stocks-to-watch/)
- [Psychedelic Therapy Without the Hallucinations: Interview with BetterLife Pharma](https://abetterlifepharma.com/media_events/psychedelic-therapy-without-the-hallucinations-interview-with-betterlife-pharma/)
- [Psychedelic Treatment for Depression Moving Toward Clinical Trials](https://abetterlifepharma.com/media_events/psychedelic-treatment-for-depression-moving-toward-clinical-trials-4/)
- [Psychedelic Treatment for Depression Moving Toward Clinical Trials](https://abetterlifepharma.com/media_events/psychedelic-treatment-for-depression-moving-toward-clinical-trials-3/)
- [Psychedelic Treatment for Depression Moving Toward Clinical Trials](https://abetterlifepharma.com/media_events/psychedelic-treatment-for-depression-moving-toward-clinical-trials-2/)
- [Psychedelic Treatment for Depression Moving Toward Clinical Trials](https://abetterlifepharma.com/media_events/psychedelic-treatment-for-depression-moving-toward-clinical-trials/)
- [Top 5 Psychedelic Developments For The Week Of January 17](https://abetterlifepharma.com/media_events/top-5-psychedelic-developments-for-the-week-of-january-17/)
- [BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder Treatment](https://abetterlifepharma.com/media_events/betterlife-receives-fda-response-on-its-pre-ind-application-for-major-depressive-disorder-treatment/)
- [BetterLife Pharma receives response from U.S. FDA on treatment of depression with BETR-001](https://abetterlifepharma.com/media_events/betterlife-pharma-receives-response-from-u-s-fda-on-treatment-of-depression-with-betr-001/)
- [BetterLife Pharma announces positive results from its in vivo oral bioavailability study on BETR-001 in beagle dogs](https://abetterlifepharma.com/media_events/betterlife-pharma-announces-positive-results-from-its-in-vivo-oral-bioavailability-study-on-betr-001-in-beagle-dogs/)
- [Company Profile](https://abetterlifepharma.com/media_events/company-profile/)
- [Depression in the US Costs $362 Billion, Psychedelic Medicine May Be the Answer](https://abetterlifepharma.com/media_events/depression-in-the-us-costs-362-billion-psychedelic-medicine-may-be-the-answer-2/)
- [10 Psychedelic Companies To Watch In 2022](https://abetterlifepharma.com/media_events/10-psychedelic-companies-to-watch-in-2022/)
- [BetterLife Pharma reports positive pre-clinical data on TD-0148A to treat depression](https://abetterlifepharma.com/media_events/betterlife-pharma-reports-positive-pre-clinical-data-on-td-0148a-to-treat-depression/)
- [The next generation of psychedelic products is here, and BetterLife Pharma is leading the charge](https://abetterlifepharma.com/media_events/the-next-generation-of-psychedelic-products-is-here-and-betterlife-pharma-is-leading-the-charge-2/)
- [Synthesized Non-Hallucinogenic LSD Puts BetterLife Pharma on Psychedelic Investors Radar](https://abetterlifepharma.com/media_events/synthesized-non-hallucinogenic-lsd-puts-betterlife-pharma-on-psychedelic-investors-radar/)
- [Non Hallucinogenic LSD? BetterLife Pharma on Psychedelic Investors Radar](https://abetterlifepharma.com/media_events/non-hallucinogenic-lsd-betterlife-pharma-on-psychedelic-investors-radar/)
- [BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property](https://abetterlifepharma.com/media_events/betterlife-pharma-says-pharmacology-data-on-second-generation-lsd-derivative-confirms-its-projected-non-hallucinogenic-property/)
- [BetterLife Pharma obtains TD-0148A neurological receptor binding data for IND-enabling pharmacology studies](https://abetterlifepharma.com/media_events/betterlife-pharma-obtains-td-0148a-neurological-receptor-binding-data-for-ind-enabling-pharmacology-studies/)
- [BetterLife Pharma releases TD-0148A receptor binding data for IND-Enabling Pharmacology study](https://abetterlifepharma.com/media_events/betterlife-pharma-releases-td-0148a-receptor-binding-data-for-ind-enabling-pharmacology-study/)
- [BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders](https://abetterlifepharma.com/media_events/betterlife-files-patent-for-td-0148a-for-treatment-of-cluster-headaches-and-related-disorders/)
- [BetterLife Pharma strikes research agreement with Medical College Wisconsin for its TD-0148A neurological receptor studies](https://abetterlifepharma.com/media_events/betterlife-pharma-strikes-research-agreement-with-medical-college-wisconsin-for-its-td-0148a-neurological-receptor-studies-2/)
- [BetterLife Pharma secures Mitacs Accelerate funding to research its chronic anxiety and depression candidate](https://abetterlifepharma.com/media_events/betterlife-pharma-secures-mitacs-accelerate-funding-to-research-its-chronic-anxiety-and-depression-candidate/)
- [BetterLife Pharma says it expects to start human trials on non-hallucinogenic LSD compound TD-0148A in 2022](https://abetterlifepharma.com/media_events/betterlife-pharma-says-it-expects-to-start-human-trials-on-non-hallucinogenic-lsd-compound-td-0148a-in-2022/)
- [BetterLife Pharma awarded funding from Mitacs Accelerate program for research on LSD to treat depression](https://abetterlifepharma.com/media_events/betterlife-pharma-awarded-funding-from-mitacs-accelerate-program-for-research-on-lsd-to-treat-depression/)
- [BETTERLIFE PHARMA RETAINS PROACTIVE INVESTORS AND PSYCHEDELIC FINANCE FOR MARKET AWARENESS](https://abetterlifepharma.com/media_events/betterlife-pharma-retains-proactive-investors-and-psychedelic-finance-for-market-awareness/)
- [BetterLife Pharma closes its C$2.6M equity offering](https://abetterlifepharma.com/media_events/betterlife-pharma-closes-its-c2-6m-equity-offering/)
- [BetterLife Pharma brings on founding partner of Conscious Fund to Board of Directors](https://abetterlifepharma.com/media_events/betterlife-pharma-brings-on-founding-partner-of-conscious-fund-to-board-of-directors/)
- [BetterLife Pharma welcomes The Conscious Fund founder Henri Sant-Cassia to its board of directors](https://abetterlifepharma.com/media_events/betterlife-pharma-welcomes-the-conscious-fund-founder-henri-sant-cassia-to-its-board-of-directors/)
- [BetterLife Pharma to raise up to C$2.6M in a public equity offering](https://abetterlifepharma.com/media_events/betterlife-pharma-to-raise-up-to-c2-6m-in-a-public-equity-offering/)
- [BetterLife Pharma closes bought-deal, over-allotted public offering that raised $6.325M](https://abetterlifepharma.com/media_events/betterlife-pharma-closes-bought-deal-over-allotted-public-offering-that-raised-6-325m/)
- [BetterLife Pharma announces $5.5M bought-deal public offering](https://abetterlifepharma.com/media_events/betterlife-pharma-announces-5-5m-bought-deal-public-offering/)
- [BetterLife Pharma files patent protection for an implant designed to mitigate excess psychedelic dosage effects](https://abetterlifepharma.com/media_events/betterlife-pharma-files-patent-protection-for-an-implant-designed-to-mitigate-excess-psychedelic-dosage-effects/)
- [BetterLife Pharma adds former FDA Psychiatry Division director as regulatory advisor](https://abetterlifepharma.com/media_events/betterlife-pharma-adds-former-fda-psychiatry-division-director-as-regulatory-advisor/)
- [Algernon Pharmaceuticals and Betterlife Pharma added to the world's first psychedelic stock ETF](https://abetterlifepharma.com/media_events/algernon-pharmaceuticals-and-betterlife-pharma-added-to-the-worlds-first-psychedelic-stock-etf/)
- [BetterLife Pharma inks research agreement with the University of California San Diego](https://abetterlifepharma.com/media_events/betterlife-pharma-inks-research-agreement-with-the-university-of-california-san-diego/)
- [BetterLife Pharma announces tie-up with Carleton University to study TD-0148A as treatment for depression](https://abetterlifepharma.com/media_events/betterlife-pharma-announces-tie-up-with-carleton-university-to-study-td-0148a-as-treatment-for-depression/)
- [NA Proactive news snapshot: PyroGenesis Canada, Energy Fuels, Biocept, EVmo, BetterLife Pharma UPDATE …](https://abetterlifepharma.com/media_events/na-proactive-news-snapshot-pyrogenesis-canada-energy-fuels-biocept-evmo-betterlife-pharma-update/)
- [BetterLife Pharma hires Eurofins CDMO to manufacture LSD derivative TD-0148A](https://abetterlifepharma.com/media_events/betterlife-pharma-hires-eurofins-cdmo-to-manufacture-lsd-derivative-td-0148a/)
- [BetterLife Pharma files patent protection for its newest compound TD-010 to treat anxiolytic-use disorder](https://abetterlifepharma.com/media_events/betterlife-pharma-files-patent-protection-for-its-newest-compound-td-010-to-treat-anxiolytic-use-disorder/)
- [BetterLife Pharma partners with Eurofins Discovery for pharmacology studies of Eurofins' LSD-derived molecule TD-0148A](https://abetterlifepharma.com/media_events/betterlife-pharma-partners-with-eurofins-discovery-for-pharmacology-studies-of-eurofins-lsd-derived-molecule-td-0148a/)
- [BetterLife Pharma forms psychedelic research advisory board and taps industry veteran Hattie Wells as its first member](https://abetterlifepharma.com/media_events/betterlife-pharma-forms-psychedelic-research-advisory-board-and-taps-industry-veteran-hattie-wells-as-its-first-member/)
- [BETTERLIFE FILES PATENT FOR THE TREATMENT OF MDD UTILIZING ITS SECOND-GENERATION PSYCHEDELIC DERIVATIVE FOR 2-BROMO-LSD](https://abetterlifepharma.com/media_events/betterlife-files-patent-for-the-treatment-of-mdd-utilizing-its-second-generation-psychedelic-derivative-for-2-bromo-lsd/)
- [BetterLife Pharma seeks patent protection for new 2-Bromo-LSD formulations to treat depression and mood disorders](https://abetterlifepharma.com/media_events/betterlife-pharma-seeks-patent-protection-for-new-2-bromo-lsd-formulations-to-treat-depression-and-mood-disorders/)
- [BetterLife Pharma adds Sergei Stetsenko to its board of directors to prepare for its growth phase in psychedelic medicines](https://abetterlifepharma.com/media_events/betterlife-pharma-adds-sergei-stetsenko-to-its-board-of-directors-to-prepare-for-its-growth-phase-in-psychedelic-medicines/)
- [BetterLife Pharma adds psychedelic industry leaders to its senior management team following recent takeover of Transcend Biodynamics](https://abetterlifepharma.com/media_events/betterlife-pharma-adds-psychedelic-industry-leaders-to-its-senior-management-team-following-recent-takeover-of-transcend-biodynamics/)
- [BETTERLIFE CLOSES ACQUISITION OF SECOND GENERATION PSYCHEDELIC ASSETS OF TRANSCEND BIODYNAMICS LLC](https://abetterlifepharma.com/media_events/betterlife-closes-acquisition-of-second-generation-psychedelic-assets-of-transcend-biodynamics-llc/)
- [BetterLife Pharma completes C$10M acquisition of LSD derivative owner Transcend Biodyanmics LLC](https://abetterlifepharma.com/media_events/betterlife-pharma-completes-c10m-acquisition-of-lsd-derivative-owner-transcend-biodyanmics-llc/)
- [BetterLife Pharma completes C$10M acquisition of LSD derivative owner Transcend Biodyanmics LLC](https://abetterlifepharma.com/media_events/betterlife-pharma-completes-c10m-acquisition-of-lsd-derivative-owner-transcend-biodyanmics-llc-2/)
- [BetterLife Pharma to Acquire Transcend Biodynamics](https://abetterlifepharma.com/media_events/betterlife-pharma-to-acquire-transcend-biodynamics/)
- [Adam Halberstadt | UC San Diego](https://abetterlifepharma.com/media_events/adam-halberstadt-uc-san-diego/)
- [Transcend Biodynamics](https://abetterlifepharma.com/media_events/transcend-biodynamics-2/)
- [Depression in the US Costs $362 Billion, Psychedelic Medicine May Be the Answer](https://abetterlifepharma.com/media_events/depression-in-the-us-costs-362-billion-psychedelic-medicine-may-be-the-answer/)
- [The next generation of psychedelic products is here, and BetterLife Pharma is leading the charge](https://abetterlifepharma.com/media_events/the-next-generation-of-psychedelic-products-is-here-and-betterlife-pharma-is-leading-the-charge/)
- [TDR’s Top 5 Psychedelic Developments For The Week Of December 6](https://abetterlifepharma.com/media_events/tdrs-top-5-psychedelic-developments-for-the-week-of-december-6/)
- [BUSINESSBetterlife Pharma Inc. (OTCMKTS: BETRF) Receives First Data Set for Its Flagships LSD-Derivative Compound In Depression Treatment](https://abetterlifepharma.com/media_events/businessbetterlife-pharma-inc-otcmkts-betrf-receives-first-data-set-for-its-flagships-lsd-derivative-compound-in-depression-treatment/)
- [TDR’s Top 5 Psychedelic Developments For The Week Of November 15](https://abetterlifepharma.com/media_events/tdrs-top-5-psychedelic-developments-for-the-week-of-november-15/)
- [BetterLife Obtains TD-0148A Behavioural Pharmacology Data Confirming its Projected Non-hallucinogenic Property](https://abetterlifepharma.com/media_events/betterlife-obtains-td-0148a-behavioural-pharmacology-data-confirming-its-projected-non-hallucinogenic-property/)
- [Better Life Pharma: Medicinal Psychedelics Without the Hallucinations](https://abetterlifepharma.com/media_events/better-life-pharma-medicinal-psychedelics-without-the-hallucinations/)
- [2021 Psychedelic Investor Guide Released](https://abetterlifepharma.com/media_events/2021-psychedelic-investor-guide-released/)
- [Canadian Biotech Company Pursuing Psychedelics with Unique Compound](https://abetterlifepharma.com/media_events/canadian-biotech-company-pursuing-psychedelics-with-unique-compound/)
- [Two New Companies On The Psychedelic Scene: Love Pharma Inc. and Delix Therapeutics](https://abetterlifepharma.com/media_events/two-new-companies-on-the-psychedelic-scene-love-pharma-inc-and-delix-therapeutics/)
- [Psychedelic Business Spotlight: October 1, 2021](https://abetterlifepharma.com/media_events/psychedelic-business-spotlight-october-1-2021/)
- [RESEARCHStudies to investigate safety of second-generation LSD derivative](https://abetterlifepharma.com/media_events/researchstudies-to-investigate-safety-of-second-generation-lsd-derivative/)
- [LSD Without The Trip: BetterLife Pharma’s Second Generation LSD Derivative Binds To Key Receptors](https://abetterlifepharma.com/media_events/lsd-without-the-trip-betterlife-pharmas-second-generation-lsd-derivative-binds-to-key-receptors/)
- [Betterlife Pharma applies for TD-0148A patent](https://abetterlifepharma.com/media_events/betterlife-pharma-applies-for-td-0148a-patent/)
- [BetterLife Pharma applies for patent protection for new 2-bromo-LSD compositions, including TD-0148A](https://abetterlifepharma.com/media_events/betterlife-pharma-applies-for-patent-protection-for-new-2-bromo-lsd-compositions-including-td-0148a/)
- [Second Generation Psychedelics: What Are They, And Do We Need Them?](https://abetterlifepharma.com/media_events/second-generation-psychedelics-what-are-they-and-do-we-need-them/)
- [BetterLife Pharma strikes research agreement with Medical College Wisconsin for its TD-0148A neurological receptor studies](https://abetterlifepharma.com/media_events/betterlife-pharma-strikes-research-agreement-with-medical-college-wisconsin-for-its-td-0148a-neurological-receptor-studies/)
- [BetterLife Pharma has a promising pipeline of psychedelic products, a coronavirus nebulizer and AP-001 cream](https://abetterlifepharma.com/media_events/betterlife-pharma-has-a-promising-pipeline-of-psychedelic-products-a-coronavirus-nebulizer-and-ap-001-cream/)
- [BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors](https://abetterlifepharma.com/media_events/betterlife-pharma-appoints-henri-sant-cassia-of-the-conscious-fund-to-its-board-of-directors/)
- [PsyCap Recap: 3 Key Takeaways From the BetterLife Pharma Presentation at Psychedelic Capital](https://abetterlifepharma.com/media_events/psycap-recap-3-key-takeaways-from-the-betterlife-pharma-presentation-at-psychedelic-capital/)
- [Horizons ETFs Completes Rebalance of World’s First Psychedelics ETF](https://abetterlifepharma.com/media_events/horizons-etfs-completes-rebalance-of-worlds-first-psychedelics-etf/)
- [BetterLife Pharma says Health Canada has confirmed LSD derivative 2-bromo-LSD is not a controlled substance](https://abetterlifepharma.com/media_events/betterlife-pharma-says-health-canada-has-confirmed-lsd-derivative-2-bromo-lsd-is-not-a-controlled-substance/)
- [BetterLife Pharma Is Developing Second Generation Psychedelics: Drugs That Leave Out The Trip](https://abetterlifepharma.com/media_events/betterlife-pharma-is-developing-second-generation-psychedelics-drugs-that-leave-out-the-trip/)
- [BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team](https://abetterlifepharma.com/media_events/betterlife-welcomes-psychedelic-industry-leaders-to-the-senior-management-team/)
- [TDR’s Top 5 Psychedelic Developments For The Week of December 21](https://abetterlifepharma.com/media_events/tdrs-top-5-psychedelic-developments-for-the-week-of-december-21/)
- [BetterLife Pharma Soars After Completing Acquisition Of Transcend Biodynamics](https://abetterlifepharma.com/media_events/betterlife-pharma-soars-after-completing-acquisition-of-transcend-biodynamics/)
- [BetterLife Pharma's new acquisition takes LSD from being experimental to a major therapeutic application](https://abetterlifepharma.com/media_events/betterlife-pharmas-new-acquisition-takes-lsd-from-being-experimental-to-a-major-therapeutic-application/)
- [BetterLife Pharma adds LSD derivative to its pipeline with C$10M Transcend Biodynamics acquisition](https://abetterlifepharma.com/media_events/betterlife-pharma-adds-lsd-derivative-to-its-pipeline-with-c10m-transcend-biodynamics-acquisition/)

## Conferences & Presentation

- [BetterLife Pharma Inc. (OTCQB: BETRF) (CSE: BETR) Emerging Growth Conference 16 - September 15, 2021](https://abetterlifepharma.com/conferences___presen/betterlife-pharma-inc-otcqb-betrf-cse-betr-emerging-growth-conference-16-september-15-2021/)
- [Arcview Access: The Future of Psychedelic Medicine Investment](https://abetterlifepharma.com/conferences___presen/arcview-access-the-future-of-psychedelic-medicine-investment/)
- [BetterLife Pharma Zoom Presentation May 18, 2021](https://abetterlifepharma.com/conferences___presen/betterlife-pharma-zoom-presentation-may-18-2021/) - Read More
- [PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid Nazeer of Wesana Health](https://abetterlifepharma.com/conferences___presen/ptsf85-ahmad-doroudian-ph-d-of-betterlife-pharma-and-dr-abid-nazeer-of-wesana-health/)
- [Better Life Pharma, Inc., (OTCQB: BETRF) Emerging Growth Conference February 17, 2021](https://abetterlifepharma.com/conferences___presen/better-life-pharma-inc-otcqb-betrf-emerging-growth-conference-february-17-2021/) - Read More
- [Biopub Webcast - BetterLife Pharma](https://abetterlifepharma.com/conferences___presen/biopub-webcast-betterlife-pharma/) - Read More
- [BetterLife Pharma, Inc. (OTCQB: BETRF) Emerging Growth Conference 12 - July 21, 2021](https://abetterlifepharma.com/conferences___presen/betterlife-pharma-inc-otcqb-betrf-emerging-growth-conference-12-july-21-2021/)
- [The FDA and Psychedelics - Where Are We Today](https://abetterlifepharma.com/conferences___presen/the-fda-and-psychedelics-where-are-we-today/)
- [BetterLife Pharma: Non-Hallucinogenic, Patient-Friendly Medicines|Benzinga Small Cap Conference 2021](https://abetterlifepharma.com/conferences___presen/betterlife-pharma-non-hallucinogenic-patient-friendly-medicinesbenzinga-small-cap-conference-2021/) - Read More
- [Non Hallucinogenic LSD? BetterLife Pharma on Psychedelic Investors Radar](https://abetterlifepharma.com/conferences___presen/non-hallucinogenic-lsd-betterlife-pharma-on-psychedelic-investors-radar/) - Read More

## Videos

- [BetterLife Pharma preclinical study showing AP-003 showing similar potency effect on COVID Variants](https://abetterlifepharma.com/videos/betterlife-pharma-preclinical-study-showing-ap-003-showing-similar-potency-effect-on-covid-variants-2/)
- [BetterLife Pharma receives response from U.S. FDA on treatment of depression with BETR-001](https://abetterlifepharma.com/videos/betterlife-pharma-receives-response-from-u-s-fda-on-treatment-of-depression-with-betr-001-2/)
- [Non-hallucinogenic LSD for a BetterLife](https://abetterlifepharma.com/videos/non-hallucinogenic-lsd-for-a-betterlife/) - Read More
- [BetterLife Pharma able to demonstrate BETR-001 Anti-Depressant activity in Preclinical Models](https://abetterlifepharma.com/videos/betterlife-pharma-able-to-demonstrate-betr-001-anti-depressant-activity-in-preclinical-models/)
- [BetterLife Pharma says it has confirmed bioavailability of BETR-001 compound in pre-clinical study](https://abetterlifepharma.com/videos/betterlife-pharma-says-it-has-confirmed-bioavailability-of-betr-001-compound-in-pre-clinical-study-2/)
- [BetterLife Pharma says it has confirmed bioavailability of BETR-001 compound in pre-clinical study](https://abetterlifepharma.com/videos/betterlife-pharma-says-it-has-confirmed-bioavailability-of-betr-001-compound-in-pre-clinical-study/) - Read More
- [Solidarity Fridays 85 - PTSF85](https://abetterlifepharma.com/videos/solidarity-fridays-85-ptsf85/)
- [BetterLife Pharma releases TD-0148A receptor binding data for IND-Enabling Pharmacology study](https://abetterlifepharma.com/videos/betterlife-pharma-releases-td-0148a-receptor-binding-data-for-ind-enabling-pharmacology-study-2/)
- [Biopub Webcast - BetterLife Pharma](https://abetterlifepharma.com/videos/biopub-webcast-betterlife-pharma/)
- [To Invest or Not: BetterLife Pharma (BETR.C)](https://abetterlifepharma.com/videos/to-invest-or-not-betterlife-pharma-betr-c/)
- [BetterLife Pharma (BETR.C) - Investor Roundtable](https://abetterlifepharma.com/videos/betterlife-pharma-betr-c-investor-roundtable/)
- [BetterLife Pharma Presentation and Q&A with CEO Ahmad Doroudian and Dr. Mark Swaim of BioPub](https://abetterlifepharma.com/videos/betterlife-pharma-presentation-and-qa-with-ceo-ahmad-doroudian-and-dr-mark-swaim-of-biopub-2/)
- [BetterLife Pharma Presentation and Q&A with CEO Ahmad Doroudian and Dr. Mark Swaim of BioPub](https://abetterlifepharma.com/videos/betterlife-pharma-presentation-and-qa-with-ceo-ahmad-doroudian-and-dr-mark-swaim-of-biopub/)
- [BetterLife Pharma Zoom Presentation May 18, 2021](https://abetterlifepharma.com/videos/betterlife-pharma-zoom-presentation-may-18-2021/)
- [Betterlife Pharma CEO Dr. Ahmad Doroudian Highlights Company Pipeline ](https://abetterlifepharma.com/videos/betterlife-pharma-ceo-dr-ahmad-doroudian-highlights-company-pipeline/)
- [BetterLife transitioning to pure-play biotech by acquiring coronavirus therapy with planned merger](https://abetterlifepharma.com/videos/betterlife-transitioning-to-pure-play-biotech-by-acquiring-coronavirus-therapy-with-planned-merger/)
- [Technical Analysis of BetterLife Pharma (PVOTF)](https://abetterlifepharma.com/videos/technical-analysis-of-betterlife-pharma-pvotf/)
- [New Listing: Better Life Pharma Inc. (CSE:BETR) - InvestmentPitch Media](https://abetterlifepharma.com/videos/new-listing-better-life-pharma-inc-csebetr-investmentpitch-media/)
- [BetterLife Pharma brings on founding partner of Conscious Fund to Board of Directors](https://abetterlifepharma.com/videos/betterlife-pharma-brings-on-founding-partner-of-conscious-fund-to-board-of-directors/) - Read More
- [BetterLife Pharma is cashed up and ready to execute on pre-clinical work in mental health](https://abetterlifepharma.com/videos/betterlife-pharma-is-cashed-up-and-ready-to-execute-on-pre-clinical-work-in-mental-health/) - Read More
- [BetterLife Pharma’s Interferon alpha-2b Covid-19 trial in Chile enrolls their first patient](https://abetterlifepharma.com/videos/betterlife-pharmas-interferon-alpha-2b-covid-19-trial-in-chile-enrolls-their-first-patient/) - Read More
- [BetterLife Pharma releases TD-0148A receptor binding data for IND-Enabling Pharmacology study](https://abetterlifepharma.com/videos/betterlife-pharma-releases-td-0148a-receptor-binding-data-for-ind-enabling-pharmacology-study/) - Read More
- [Non Hallucinogenic LSD? BetterLife Pharma on Psychedelic Investors Radar](https://abetterlifepharma.com/videos/non-hallucinogenic-lsd-betterlife-pharma-on-psychedelic-investors-radar/) - Read More
- [BetterLife Pharma completes Phase 1 clinical trial on AP-003, starts Phase 2](https://abetterlifepharma.com/videos/betterlife-pharma-completes-phase-1-clinical-trial-on-ap-003-starts-phase-2/) - Read More
- [BetterLife Pharma subsidiary Altum Pharmaceuticals receives strategic investment](https://abetterlifepharma.com/videos/betterlife-pharma-subsidiary-altum-pharmaceuticals-receives-strategic-investment/) - Read More
- [Betterlife Pharma The Business of Psychedelics: Episode 4](https://abetterlifepharma.com/videos/betterlife-pharma-the-business-of-psychedelics-episode-4/) - Read More
- [Betterlife Pharma The Business of Psychedelics: Episode 3](https://abetterlifepharma.com/videos/betterlife-pharma-the-business-of-psychedelics-episode-3/) - Read More
- [Betterlife Pharma The Business of Psychedelics: Episode 2](https://abetterlifepharma.com/videos/betterlife-pharma-the-business-of-psychedelics-episode-2/) - Read More
- [Betterlife Pharma The Business of Psychedelics: Episode 1](https://abetterlifepharma.com/videos/betterlife-pharma-the-business-of-psychedelics-episode-1/) - Read More
- [In Conversation with A BetterLife Pharma; focused on novel psychadelic and anti-viral drugs.](https://abetterlifepharma.com/videos/in-conversation-with-a-betterlife-pharma-focused-on-novel-psychadelic-and-anti-viral-drugs/) - Read More
- [Drugs are NOT the Problem": Patrick Kroupa, CPO BetterLife Pharma | Psychedelic Capital Apr '21](https://abetterlifepharma.com/videos/drugs-are-not-the-problem-patrick-kroupa-cpo-betterlife-pharma-psychedelic-capital-apr-21/) - Read More
- [BetterLife reveals clinical trial updates on its treatment for mild-to-moderate coronavirus cases](https://abetterlifepharma.com/videos/betterlife-reveals-clinical-trial-updates-on-its-treatment-for-mild-to-moderate-coronavirus-cases/) - Read More
- [Dr. Ahmad Doroudian on the Potential of a COVID-19 Treatment | BetterLife Pharma (CSE:BETR)](https://abetterlifepharma.com/videos/dr-ahmad-doroudian-on-the-potential-of-a-covid-19-treatment-betterlife-pharma-csebetr/) - Read More
- [Learn About Public Companies Combating COVID-19 | CSE Presents TECH TUESDAYS](https://abetterlifepharma.com/videos/learn-about-public-companies-combating-covid-19-cse-presents-tech-tuesdays/) - Read More
- [BetterLife surges on UK biotech trial results of interferon inhalation treatment for coronavirus](https://abetterlifepharma.com/videos/betterlife-surges-on-uk-biotech-trial-results-of-interferon-inhalation-treatment-for-coronavirus/)
- [NEW SECRET PICK: BETTERLIFE PHARMA (CSE: BETR) (OTCQB: BETRD)](https://abetterlifepharma.com/videos/new-secret-pick-betterlife-pharma-cse-betr-otcqb-betrd/)
- [BetterLife Pharma reveals finalized rebranding by launching its new website](https://abetterlifepharma.com/videos/betterlife-pharma-reveals-finalized-rebranding-by-launching-its-new-website/)
- [BetterLife Pharma preclinical study showing AP-003 showing similar potency effect on COVID Variants](https://abetterlifepharma.com/videos/betterlife-pharma-preclinical-study-showing-ap-003-showing-similar-potency-effect-on-covid-variants/)

## Events

- [Laryngological Clinic](https://abetterlifepharma.com/events/laryngological-clinic/) - Diagnostics Bronchoscopy From $ 250 Parathyroid scan From $ 49 Orthotics From $ 117 Captopril Renography From $ 65 Full Blood Count From $ 34 Head CT From $ 220 view full list Treatments Digestive care From $ 350 Dialysis From $ 200 Fertility From $ 600 Infusion therapy From $ 65 Lymphedema therapy From
- [Neurology Clinic](https://abetterlifepharma.com/events/neurology-clinic/) - Diagnostics Bronchoscopy From $ 250 Parathyroid scan From $ 49 Orthotics From $ 117 Captopril Renography From $ 65 Full Blood Count From $ 34 Head CT From $ 220 view full list Treatments Digestive care From $ 350 Dialysis From $ 200 Fertility From $ 600 Infusion therapy From $ 65 Lymphedema therapy From
- [Outpatient Surgery](https://abetterlifepharma.com/events/outpatient-surgery/) - Diagnostics Bronchoscopy From $ 250 Parathyroid scan From $ 49 Orthotics From $ 117 Captopril Renography From $ 65 Full Blood Count From $ 34 Head CT From $ 220 view full list Treatments Digestive care From $ 350 Dialysis From $ 200 Fertility From $ 600 Infusion therapy From $ 65 Lymphedema therapy From
- [Cardiology Clinic](https://abetterlifepharma.com/events/cardiology-clinic/) - Diagnostics Bronchoscopy From $ 250 Parathyroid scan From $ 49 Orthotics From $ 117 Captopril Renography From $ 65 Full Blood Count From $ 34 Head CT From $ 220 view full list Treatments Digestive care From $ 350 Dialysis From $ 200 Fertility From $ 600 Infusion therapy From $ 65 Lymphedema therapy From
- [Gynecological Clinic](https://abetterlifepharma.com/events/gynecological-clinic/) - Diagnostics Bronchoscopy From $ 250 Parathyroid scan From $ 49 Orthotics From $ 117 Captopril Renography From $ 65 Full Blood Count From $ 34 Head CT From $ 220 view full list Treatments Digestive care From $ 350 Dialysis From $ 200 Fertility From $ 600 Infusion therapy From $ 65 Lymphedema therapy From
- [Dental Clinic](https://abetterlifepharma.com/events/dental-clinic/) - Diagnostics Bronchoscopy From $ 250 Parathyroid scan From $ 49 Orthotics From $ 117 Captopril Renography From $ 65 Full Blood Count From $ 34 Head CT From $ 220 view full list Treatments Digestive care From $ 350 Dialysis From $ 200 Fertility From $ 600 Infusion therapy From $ 65 Lymphedema therapy From
- [Pediatric Clinic](https://abetterlifepharma.com/events/pediatric-clinic/) - Diagnostics Bronchoscopy From $ 250 Parathyroid scan From $ 49 Orthotics From $ 117 Captopril Renography From $ 65 Full Blood Count From $ 34 Head CT From $ 220 view full list Treatments Digestive care From $ 350 Dialysis From $ 200 Fertility From $ 600 Infusion therapy From $ 65 Lymphedema therapy From
- [Primary Health Care](https://abetterlifepharma.com/events/primary-health-care/) - Diagnostics Bronchoscopy From $ 250 Parathyroid scan From $ 49 Orthotics From $ 117 Captopril Renography From $ 65 Fool Blood Count From $ 34 Head CT From $ 220 view full list Treatments Digestive care From $ 350 Dialysis From $ 200 Fertility From $ 600 Infusion therapy From $ 65 Lymphedema therapy From

## Categories

- [Uncategorized](https://abetterlifepharma.com/category/uncategorized/)
- [GlobeNewswire](https://abetterlifepharma.com/category/globenewswire/)
- [SEC Filings](https://abetterlifepharma.com/category/sec-filings/)
- [CFN Media Group](https://abetterlifepharma.com/category/cfn-media-group/)
- [Proactive](https://abetterlifepharma.com/category/proactive/)
- [Company](https://abetterlifepharma.com/category/company/)
- [TDM Financial](https://abetterlifepharma.com/category/tdm-financial/)
- [BetterLIfe Pharma PR](https://abetterlifepharma.com/category/betterlife-pharma-pr/)

## Categories

- [Chief Executive Officer & Director](https://abetterlifepharma.com/team-category/chief-executive-officer-director/)
- [Board of Directors](https://abetterlifepharma.com/team-category/board-of-directors/)

## Categories

- [Health](https://abetterlifepharma.com/testimonials-category/health/)
- [Hospital](https://abetterlifepharma.com/testimonials-category/hospital/)
- [Laboratory](https://abetterlifepharma.com/testimonials-category/laboratory/)
- [Nutrition](https://abetterlifepharma.com/testimonials-category/nutrition/)
- [Ophthalmology](https://abetterlifepharma.com/testimonials-category/ophthalmology/)
- [Pharmacy](https://abetterlifepharma.com/testimonials-category/pharmacy/)
- [Physiatrist](https://abetterlifepharma.com/testimonials-category/physiatrist/)

## Categories

- [Media](https://abetterlifepharma.com/conferences/media/)

## Categories

- [Cardiology](https://abetterlifepharma.com/events_category/cardiology/)
- [Geriatrics](https://abetterlifepharma.com/events_category/geriatrics/)
- [Health](https://abetterlifepharma.com/events_category/health/)
- [Oftalmology](https://abetterlifepharma.com/events_category/oftalmology/)